GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for putative deoxyribonuclease TATDN3 (Q17R31)

Analyse AlphaFold monomer V2.0 prediction for putative deoxyribonuclease TATDN3 (Q17R31) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q17R31
Type
protein
Length
274 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBeF036C04BE8b62aF43C82A9ec62223aAa892154
Molecule
Putative deoxyribonuclease TATDN3
UniProt
Q17R31
Pockets
2 · best druggability 0.51

Structure

1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APutative deoxyribonuclease TATDN3protein27449% helix, 15% strandQ17R31

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12280.510.7629empty
2510.380.8014empty

Compared structures

  • 2Y1H · Crystal structure of the human tatd-domain protein 3 (TATDN3) · an experimental structure of the same protein · chain A against B, TM-score 0.97
  • 2Y1H · Crystal structure of the human TatD-domain protein 3 (TATDN3) · an experimental structure of the same protein · chain A against B, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.